Immunome Inc (IMNM)

Immunome Inc (IMNM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.1B; returns 1 day -1.5%, 1 week +9.2%, 1 year +12.0%.

Immunome Inc. is a clinical-stage biotechnology company primarily focused on discovering and developing first-in-class and best-in-class targeted cancer therapies. The company's revenue generation is currently derived from collaboration agreements, as it does not yet have any approved commercial products on the market.

Groups IMNM belongs to

• Biotechnology
• Oncology
• Clinical Stage Biotech
• Healthcare
• Antibody-Drug Conjugates
• Clinical Stage
• Biopharmaceutical
• Cancer Therapeutics
• Drug Discovery
• Life Sciences

IMNM financial model: income statement, cash flow and balance sheet